These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 22024192)
21. In vitro studies of investigational beta-lactams as possible therapy for Pseudomonas aeruginosa endocarditis. Zar FA; Kany RJ Antimicrob Agents Chemother; 1985 Jan; 27(1):1-3. PubMed ID: 3920956 [TBL] [Abstract][Full Text] [Related]
22. Chequerboard titrations: the influence of the composition of serial dilutions of antibiotics on the fractional inhibitory concentration index and fractional bactericidal concentration index. Horrevorts AM; de Ridder CM; Poot MC; de Jonge MJ; Degener JE; Dzoljic-Danilovic G; Michel MF; Kerrebijn KF J Antimicrob Chemother; 1987 Jan; 19(1):119-25. PubMed ID: 3104274 [TBL] [Abstract][Full Text] [Related]
23. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Parry MF; Neu HC J Clin Microbiol; 1977 Jan; 5(1):58-61. PubMed ID: 401831 [TBL] [Abstract][Full Text] [Related]
24. Addition of rifampin to ticarcillin-tobramycin combination for the treatment of Pseudomonas aeruginosa infections: assessment in a neutropenic mouse model. Zuravleff JJ; Chervenick P; Yu VL; Muder RR; Diven WF J Lab Clin Med; 1984 Jun; 103(6):878-85. PubMed ID: 6427375 [TBL] [Abstract][Full Text] [Related]
25. Latamoxef in combination with aminoglycosides against Pseudomonas aeruginosa: similarity with ticarcillin. Sears SD; Tatem BA; Standiford HC Chemotherapy; 1985; 31(2):102-11. PubMed ID: 3921317 [TBL] [Abstract][Full Text] [Related]
26. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin. Chusid MJ; Davis SD; Sarff LD J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the antibacterial activity of azlocillin and ticarcillin in vitro and in irradiated neutropenic mice. van der Voet GB; Mattie H; van Furth R J Antimicrob Chemother; 1985 Nov; 16(5):605-13. PubMed ID: 3935638 [TBL] [Abstract][Full Text] [Related]
28. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Shawar RM; MacLeod DL; Garber RL; Burns JL; Stapp JR; Clausen CR; Tanaka SK Antimicrob Agents Chemother; 1999 Dec; 43(12):2877-80. PubMed ID: 10582875 [TBL] [Abstract][Full Text] [Related]
29. [Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa]. Thabaut A; Meyran M Pathol Biol (Paris); 1988 May; 36(5):472-6. PubMed ID: 3136428 [TBL] [Abstract][Full Text] [Related]
30. Comparison of antimicrobial susceptibilities of Pseudomonas aeruginosa isolates, with and without plaques, from two hospitals. Flournoy DJ; Belobraydic KA; Qadri SM Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):391-2. PubMed ID: 3090386 [TBL] [Abstract][Full Text] [Related]
31. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units]. Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273 [TBL] [Abstract][Full Text] [Related]
32. Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa. White AR; Comber KR; Sutherland R Antimicrob Agents Chemother; 1980 Jul; 18(1):182-9. PubMed ID: 6774663 [TBL] [Abstract][Full Text] [Related]
33. Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa. Fernandes CJ; Stevens DA; Ackerman VP Chemotherapy; 1985; 31(4):292-6. PubMed ID: 3928282 [TBL] [Abstract][Full Text] [Related]
34. Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media. Maduri-Traczewski M; L'Heureux C; Escalona L; Macone A; Goldmann D Diagn Microbiol Infect Dis; 1986 Nov; 5(4):299-305. PubMed ID: 3096628 [TBL] [Abstract][Full Text] [Related]
35. The in vitro effect of three antibiotics on alveolar macrophages. Oliver AM; Weir DM J Clin Lab Immunol; 1985 Jun; 17(2):85-9. PubMed ID: 4045999 [TBL] [Abstract][Full Text] [Related]
36. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae. Shah PP; Briedis DJ; Robson HG; Conterato JP Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609 [TBL] [Abstract][Full Text] [Related]
37. Pan X; Dong Y; Fan Z; Liu C; Xia B; Shi J; Bai F; Jin Y; Cheng Z; Jin S; Wu W Front Cell Infect Microbiol; 2017; 7():83. PubMed ID: 28352614 [TBL] [Abstract][Full Text] [Related]
38. Pseudomonas aeruginosa keratitis treated with ticarcillin and tobramycin. Prociv P Med J Aust; 1979 Jul; 2(2):63-4. PubMed ID: 114740 [TBL] [Abstract][Full Text] [Related]
39. Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa. Khalil H; Chen T; Riffon R; Wang R; Wang Z Antimicrob Agents Chemother; 2008 May; 52(5):1635-41. PubMed ID: 18285485 [TBL] [Abstract][Full Text] [Related]
40. Importance of methodology in determining bactericidal and bacteriostatic activities of azlocillin and ticarcillin against Pseudomonas aeruginosa. Brumfitt W; Hamilton-Miller JM; Gooding A J Med Microbiol; 1984 Feb; 17(1):37-44. PubMed ID: 6420572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]